Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

XSpray Pharma AB (publ)

Closing information (x1000 NOK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 1,989 Less Arrow 684 Less Arrow 4
Earnings before taxes -294,615 More Arrow -182,026 More Arrow -94,302
EBITDA -296,025 More Arrow -184,102 More Arrow -95,526
Total assets 821,268 Less Arrow 775,236 Less Arrow 607,469
Current assets 242,423 Less Arrow 220,654 More Arrow 275,076
Current liabilities 150,714 Less Arrow 40,423 Less Arrow 29,224
Equity capital 642,597 More Arrow 702,449 Less Arrow 577,090
- share capital 38,300 Less Arrow 31,661 Less Arrow 20,168
Employees (average) 26 Equal arrow 26 Less Arrow 22

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2021/12 (consolidated)
Solvency 78.2% More Arrow 90.6% More Arrow 95.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -35.6% More Arrow -23.4% More Arrow -15.5%
Current ratio 160.8% More Arrow 545.9% More Arrow 941.3%
Return on equity (ROE) -45.8% More Arrow -25.9% More Arrow -16.3%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 4 Less Arrow 2
Chg. No. of employees % 0% More Arrow 18% Less Arrow 10%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.